Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_assertion type Assertion NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_head.
- NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_assertion description "[These results suggest that FGF21 could be a novel and attractive drug candidate for the treatment of cardiovascular disease, obesity and type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_provenance.
- NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_assertion evidence source_evidence_literature NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_provenance.
- NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_assertion SIO_000772 19337957 NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_provenance.
- NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_assertion wasDerivedFrom befree-20150227 NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_provenance.
- NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_assertion wasGeneratedBy ECO_0000203 NP882979.RAzOt_dMKhY2x7AFV615AkQE6wpisT1bMkFe_-XlaWs-A130_provenance.